Leading China based biotech company with a highly efficient clinical development platform, contributing to the translation of research outcomes into new drugs to fill unmet needs. - Innovation based model leveraging China and South Africa to foster clinical development – allows for testing in Asian, Caucasian and African subsets. - Access to leading international academic institutions and its researchers and scientists - Targeting China disease areas with a high unmet medical need and affordibility challenge. - Team with experience in GLOBAL and CHINA based clinical trials – critical to success is study design and placement of studies in leading Chinese and South African drug development sites.